ParadeDB Entity Framework Core
If you’ve ever tried to use ParadeDB‘s pg_search extension with EF Core, you know the pain. You want BM25 full-text […]

AI Researcher
I'm a PhD candidate in Artificial Intelligence at Instituto Superior Técnico, conducting research in computer vision and natural language generation at INESC-ID. With over 8 years of experience in software engineering and a growing portfolio of research articles in computer vision, NLP, and reinforcement learning, my work bridges cutting-edge AI research with real-world impact.
In my free time, I analyze the stock market — especially small-cap turnaround companies — looking for potential multibaggers through fundamental analysis and long-term investing strategies. On this blog, I share both insights from my research in artificial intelligence and my thoughts on investing.
Whether you're here for the AI, the investing insights, or both — I hope you find something valuable in what I share.
My open source projects and contributions
If you’ve ever tried to use ParadeDB‘s pg_search extension with EF Core, you know the pain. You want BM25 full-text […]
One of the recurring challenges when building AI agents is giving the LLM a safe, accurate view of your database […]
Yesterday, I shared Claude Code Status Line, a small shell script that surfaces your model info, token usage, and rate […]
Claude Code Status Line — Now with Windows Support Read More »
My latest research papers in computer vision, natural language processing, and reinforcement learning
I’m happy to share our latest research on visual storytelling. This work tackles a critical limitation in current storytelling models: […]
I’m happy to share my latest research on visual storytelling. This work addresses a challenge in LLMs: teaching models to […]
Entity Re-identification in Visual Storytelling via Contrastive Reinforcement Learning Read More »
I’m happy to share my latest research on visual storytelling. This work addresses a critical challenge in AI systems: generating […]
Research-driven analysis of smallcap stocks and stock market dynamics
Welcome back to our ongoing analysis of Emergent BioSolutions (NYSE: EBS). As we enter Q4 2024, the company has made […]
Emergent BioSolutions Q3 2024 Analysis and Q4 Forecast Read More »
Hey there, fellow value investors! It’s time to dive into one of the companies I’ve been keeping a close eye […]
Emergent BioSolutions Q2 2024 Analysis and Q3 Forecast Read More »